Latin America Dialysis Market Value Analysis

Name: Latin America Dialysis Market Value Analysis | 2025-2030
Creator: Next Move Strategy Consulting
Published: 2026-03-08T20:00:00-04:00
License: https://www.nextmsc.com/privacy-policy

About Report

Download Now

Latin America Dialysis Market By Modality [Hemodialysis {Hemodialysis Machines (In-center HD, Home HD), Water Treatment Systems (Central water-disinfection units, Point-of-use/portable systems), and Others}, Peritoneal Dialysis (PD Cyclers, Ancillary PD Equipment, and Others)], By End-User (Hospitals, Dialysis Centers, Homecare, and Ambulatory Surgical Centers) – Opportunity Analysis and Industry Forecast, 2025–2030

Download PDF

Speak to Our Analyst

Industry Outlook

The Latin America Dialysis Market size was valued at USD 8.13 billion in 2024 and is expected to reach USD 9.38 billion by 2025. Looking ahead, the market is projected to expand significantly, reaching USD 13.96 billion by 2030, at a CAGR of 8.26% from 2025 to 2030.

Growth in the Latin America region is being driven by the increasing prevalence of chronic kidney disease (CKD), diabetes, and hypertension, coupled with rising awareness about kidney health. Expanding healthcare infrastructure, growing government initiatives, and improved insurance coverage are enhancing access to dialysis therapies. Additionally, the adoption of home-based and portable dialysis systems, along with technological advancements in hemodialysis and peritoneal dialysis, is improving treatment efficiency, patient convenience, and clinical outcomes across Latin America.

Rising Burden of Chronic Kidney Disease Drives Latin America Dialysis Market Growth

Latin America is witnessing a significant increase in CKD cases due to the growing prevalence of diabetes, hypertension, and lifestyle-related health conditions. As CKD progresses to end-stage renal disease, the demand for dialysis therapies rises sharply. Early detection programs, public awareness campaigns, and expanding healthcare access are enabling timely treatment. Countries such as Brazil and Mexico are investing in advanced dialysis infrastructure and equipment, increasing the availability of both hospital-based and home-based treatment options. These factors collectively drive robust growth in the Latin America dialysis market.

Adoption of Home-Based and Portable Dialysis Solutions Boosts Latin America Dialysis Market Demand

Home-based and portable dialysis therapies are increasingly being adopted in Latin America, allowing patients to receive treatment at home and reducing dependence on hospitals. Portable dialysis systems and user-friendly devices improve convenience, flexibility, and quality of life. Government programs, reimbursement schemes, and patient training initiatives are facilitating the adoption of these therapies. Integration of digital monitoring tools and telehealth platforms allows clinicians to remotely track treatment progress, improving safety and treatment outcomes. These trends are accelerating market growth across urban and semi-urban populations.

High Cost and Limited Pose Challenges to Widespread Adoption

The dialysis market in Latin America faces challenges due to high treatment costs and uneven healthcare infrastructure. Establishing dialysis centers requires significant investment in machinery, skilled personnel, and ongoing operational expenses. Limited access to advanced or home-based dialysis systems in rural areas, combined with high out-of-pocket costs, restricts market penetration. These financial and infrastructural barriers remain key restraints on widespread adoption, particularly in less-developed regions.

Technological Advancements and Government Initiatives Present Opportunities

Technological innovation and supportive government programs offer major growth opportunities in Latin America. Smart dialysis machines, portable devices, and remote monitoring platforms are improving patient care and treatment efficiency. Expansion of home-based dialysis solutions, backed by public health initiatives and insurance coverage, is increasing accessibility and convenience. Continued investments in healthcare infrastructure and growing awareness of kidney health are expected to drive demand for innovative dialysis therapies, positioning the Latin America market for significant expansion in the coming years.

Competitive Landscape

The market players operating in the Latin America dialysis industry include Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Baxter International Inc., Diaverum Deutschland GmbH, Nipro Corporation, B. Braun, Becton, Dickinson and Company, Toray Medical Co., Ltd., Terumo Corporation, W. L. Gore & Associates, Inc., and Others.

Latin America Dialysis Market Key Segments

By Modality

Hemodialysis (HD)
- Hemodialysis Machines
  - In-center HD
  - Home HD
- Water Treatment Systems
  - Central water-disinfection units
  - Point-of-use/portable systems
- Ancillary/Other HD Equipment
  - UF/ultrafiltration pumps
  - Dialysis chairs/beds
  - Disinfection/sterilization units
  - Monitoring & data-capture hardware
- HD Consumables & Supplies
  - Dialyzers
  - Bloodlines & Tubing Sets
  - Dialysis Fluids / Concentrates
  - Vascular Access Products
  - Other HD Consumables & Accessories
- HD Aftermarket Services
  - Repair & Maintenance
  - Installation & Commissioning
  - Training & Technical Support
Peritoneal Dialysis (PD)
- PD Cyclers / Automated PD Machines
- Ancillary PD Equipment
- PD Consumables & Supplies
  - PD Dialysis Solutions
  - PD Catheters & Access Systems
  - Transfer Sets & Tubing
  - Other PD Supplies / Accessories
- PD Aftermarket Services
  - Repair & Maintenance (Cyclers & Heaters)
  - Installation & Commissioning
  - Training & Technical Support

By End-User

Hospitals
Dialysis Centers
Homecare
Ambulatory Surgical Centers

By Region

Saudi Arabia
United Arab Emirates (UAE)
Israel
Qatar
Kuwait
Oman
Other Countries

Key Players

Fresenius Medical Care AG and Co. KGaA
DaVita Inc.
Baxter International Inc.
Diaverum Deutschland GmbH
Nipro Corporation
B Braun
Becton, Dickinson and Company.
Toray Medical Co,.Ltd.
Terumo Corporation
W. L. Gore & Associates, Inc.
Teleflex Incorporated
Quanta Dialysis Technologies Ltd
Vantive Health LLC
Vygon

Report Scope and Segmentation

Parameters	Details
Market Size in 2025	USD 9.38 billion
Revenue Forecast in 2030	USD 13.96 billion
Growth Rate	CAGR of 8.26% from 2025 to 2030
Analysis Period	2024–2030
Base Year Considered	2024
Forecast Period	2025–2030
Market Size Estimation	Billion (USD)
Growth Factors	Rising burden of chronic kidney disease drives market growth Adoption of home-based and portable dialysis solutions boosts market demand
Companies Profiled	14
Market Share	Available for 10 companies
Customization Scope	Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.

About the Author

Mayurima Roy is a research analyst delivering data-driven insights that support strategic planning and market understanding. She combines analytical rigor with strong content development skills, translating complex information into clear, actionable narratives for diverse audiences. Her work includes structured research, trend tracking, competitive assessment, and insight-led content creation that supports informed decision-making. Curious and detail-oriented by nature, she continually deepens her understanding of evolving markets while pursuing creative interests such as crafting and video creation.

About the Reviewer

Supradip Baul is an accomplished business consultant and strategist with over a decade of rich experience in market intelligence, strategy, technology, and business transformation. His work has included rigorous qualitative and quantitative analysis across multiple industries, helping clients shape investment decisions and long-term roadmaps. Earlier in his career, he was associated with Gartner, where he contributed to industry-leading reports and market share analyses. He has worked with leading global companies and holds an MBA with a dual specialization in Marketing and Finance.

1. 1.1 REPORT DESCRIPTION
2. 1.2 RESEARCH METHODOLOGY
3. 1. 1.2.1 SECONDARY RESEARCH
  2. 1.2.2 DATA ANALYSIS FRAMEWORK
  3. 1.2.3 MARKET SIZE ESTIMATION
  4. 1.2.4 FORECASTING
  5. 1.2.5 PRIMARY RESEARCH AND DATA VALIDATION

1. 2.1. MARKET SNAPSHOT, 2024 - 2030, BILLION USD

1. 3.1 BARGAINING POWER OF SUPPLIERS
2. 3.2 BARGAINING POWER OF BUYERS
3. 3.3 DEGREE OF COMPETITION
4. 3.4 THREAT OF SUBSTITUTE
5. 3.5 THREAT OF NEW ENTRANTS

1. 4.1 MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2024

1. 5.1 GROWTH DRIVERS
2. 1. 5.1.1 RISING BURDEN OF CHRONIC KIDNEY DISEASE DRIVES LATIN AMERICA DIALYSIS MARKET GROWTH
  2. 5.1.2 ADOPTION OF HOME-BASED AND PORTABLE DIALYSIS SOLUTIONS BOOSTS LATIN AMERICA DIALYSIS MARKET DEMAND
3. 5.2 CHALLENGES
4. 1. 5.2.1 HIGH COST AND LIMITED POSE CHALLENGES TO WIDESPREAD ADOPTION
5. 5.3 OPPORTUNITIES
6. 1. 5.3.1 TECHNOLOGICAL ADVANCEMENTS AND GOVERNMENT INITIATIVES PRESENT OPPORTUNITIES

1. 6.1 OVERVIEW
2. 6.2 HEMODIALYSIS (HD)
3. 1. 6.2.1 HEMODIALYSIS (HD) MARKET, BY MODALITY
  2. 1. 6.2.1.1 HEMODIALYSIS MACHINES MARKET, BY COUNTRY
    2. 1. 6.2.1.1.1 IN-CENTER HD
      2. 6.2.1.1.2 HOME HD
    3. 6.2.1.2 WATER TREATMENT SYSTEMS MARKET, BY COUNTRY
    4. 1. 6.2.1.2.1 CENTRAL WATER-DISINFECTION UNITS
      2. 6.2.1.2.2 POINT-OF-USE/PORTABLE SYSTEMS
    5. 6.2.1.3 ANCILLARY/OTHER HD EQUIPMENT MARKET, BY COUNTRY
    6. 1. 6.2.1.3.1 UF/ULTRAFILTRATION PUMPS
      2. 6.2.1.3.2 DIALYSIS CHAIRS/BEDS
      3. 6.2.1.3.3 DISINFECTION/STERILIZATION UNITS
      4. 6.2.1.3.4 MONITORING & DATA-CAPTURE HARDWARE
    7. 6.2.1.4 HD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
    8. 1. 6.2.1.4.1 DIALYZERS
      2. 6.2.1.4.2 BLOODLINES & TUBING SETS
      3. 6.2.1.4.3 DIALYSIS FLUIDS / CONCENTRATES
      4. 6.2.1.4.4 VASCULAR ACCESS PRODUCTS
      5. 6.2.1.4.5 OTHER HD CONSUMABLES & ACCESSORIES
    9. 6.2.1.5 HD AFTERMARKET SERVICES MARKET, BY COUNTRY
    10. 1. 6.2.1.5.1 REPAIR & MAINTENANCE
      2. 6.2.1.5.2 INSTALLATION & COMMISSIONING
      3. 6.2.1.5.3 TRAINING & TECHNICAL SUPPORT
  3. 6.2.2 HEMODIALYSIS (HD) MARKET, BY COUNTRY
4. 6.3 PERITONEAL DIALYSIS (PD)
5. 1. 6.3.1 PERITONEAL DIALYSIS (PD) MARKET, BY MODALITY
  2. 1. 6.3.1.1 PD CYCLERS / AUTOMATED PD MACHINES MARKET, BY COUNTRY
    2. 6.3.1.2 ANCILLARY PD EQUIPMENT MARKET, BY COUNTRY
    3. 6.3.1.3 PD CONSUMABLES AND SUPPLIES MARKET, BY COUNTRY
    4. 1. 6.3.1.3.1 PD DIALYSIS SOLUTIONS
      2. 6.3.1.3.2 PD CATHETERS & ACCESS SYSTEMS
      3. 6.3.1.3.3 TRANSFER SETS & TUBING
      4. 6.3.1.3.4 OTHER PD SUPPLIES / ACCESSORIES
    5. 6.3.1.4 PD AFTERMARKET SERVICES MARKET, BY COUNTRY
    6. 1. 6.3.1.4.1 REPAIR & MAINTENANCE (CYCLERS & HEATERS)
      2. 6.3.1.4.2 INSTALLATION & COMMISSIONING
      3. 6.3.1.4.3 TRAINING & TECHNICAL SUPPORT
  3. 6.3.2 PERITONEAL DIALYSIS (PD) MARKET, BY COUNTRY

1. 7.1 OVERVIEW
2. 7.2 HOSPITALS
3. 1. 7.2.1 HOSPITALS MARKET, BY COUNTRY
4. 7.3 DIALYSIS CENTERS
5. 1. 7.3.1 DIALYSIS CENTERS MARKET, BY COUNTRY
6. 7.4 HOMECARE
7. 1. 7.4.1 HOMECARE MARKET, BY COUNTRY
8. 7.5 AMBULATORY SURGICAL CENTERS
9. 1. 7.5.1 AMBULATORY SURGICAL CENTERS MARKET, BY COUNTRY

1. 8.1 OVERVIEW
2. 8.2 ARGENTINA
3. 1. 8.2.1 ARGENTINA DIALYSIS MARKET, BY MODALITY
  2. 8.2.2 ARGENTINA DIALYSIS MARKET, BY END-USER
4. 8.3 BRAZIL
5. 1. 8.3.1 BRAZIL DIALYSIS MARKET, BY MODALITY
  2. 8.3.2 BRAZIL DIALYSIS MARKET, BY END-USER
6. 8.4 CHILE
7. 1. 8.4.1 CHILE DIALYSIS MARKET, BY MODALITY
  2. 8.4.2 CHILE DIALYSIS MARKET, BY END-USER
8. 8.5 COLUMBIA
9. 1. 8.5.1 COLUMBIA DIALYSIS MARKET, BY MODALITY
  2. 8.5.2 COLUMBIA DIALYSIS MARKET, BY END-USER
10. 8.6 REST OF LATAM
11. 1. 8.6.1 REST OF LATAM DIALYSIS MARKET, BY MODALITY
  2. 8.6.2 REST OF LATAM DIALYSIS MARKET, BY END-USER

1. 9.1 FRESENIUS MEDICAL CARE AG AND CO. KGAA
2. 1. 9.1.1 COMPANY OVERVIEW
  2. 9.1.2 COMPANY SNAPSHOT
  3. 9.1.3 OPERATING BUSINESS SEGMENTS
  4. 9.1.4 PRODUCT PORTFOLIO
  5. 9.1.5 BUSINESS PERFORMANCE
  6. 9.1.6 BUSINESS SEGMENTS
  7. 9.1.7 GEOGRAPHIC SEGMENTS
  8. 9.1.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.1.9 PRIMARY MARKET COMPETITORS
3. 9.2 DAVITA INC.
4. 1. 9.2.1 COMPANY OVERVIEW
  2. 9.2.2 COMPANY SNAPSHOT
  3. 9.2.3 OPERATING BUSINESS SEGMENTS
  4. 9.2.4 PRODUCT PORTFOLIO
  5. 9.2.5 BUSINESS PERFORMANCE
  6. 9.2.6 BUSINESS SEGMENTS
  7. 9.2.7 GEOGRAPHIC SEGMENTS
  8. 9.2.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.2.9 PRIMARY MARKET COMPETITORS
5. 9.3 BAXTER INTERNATIONAL INC.
6. 1. 9.3.1 COMPANY OVERVIEW
  2. 9.3.2 COMPANY SNAPSHOT
  3. 9.3.3 OPERATING BUSINESS SEGMENTS
  4. 9.3.4 PRODUCT PORTFOLIO
  5. 9.3.5 BUSINESS PERFORMANCE
  6. 9.3.6 BUSINESS SEGMENTS
  7. 9.3.7 GEOGRAPHIC SEGMENTS
  8. 9.3.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.3.9 PRIMARY MARKET COMPETITORS
7. 9.4 DIAVERUM DEUTSCHLAND GMBH
8. 1. 9.4.1 COMPANY OVERVIEW
  2. 9.4.2 COMPANY SNAPSHOT
  3. 9.4.3 OPERATING BUSINESS SEGMENTS
  4. 9.4.4 PRODUCT PORTFOLIO
  5. 9.4.5 BUSINESS PERFORMANCE
  6. 9.4.6 BUSINESS SEGMENTS
  7. 9.4.7 GEOGRAPHIC SEGMENTS
  8. 9.4.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.4.9 PRIMARY MARKET COMPETITORS
9. 9.5 NIPRO CORPORATION
10. 1. 9.5.1 COMPANY OVERVIEW
  2. 9.5.2 COMPANY SNAPSHOT
  3. 9.5.3 OPERATING BUSINESS SEGMENTS
  4. 9.5.4 PRODUCT PORTFOLIO
  5. 9.5.5 BUSINESS PERFORMANCE
  6. 9.5.6 BUSINESS SEGMENTS
  7. 9.5.7 GEOGRAPHIC SEGMENTS
  8. 9.5.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.5.9 PRIMARY MARKET COMPETITORS
11. 9.6 B BRAUN
12. 1. 9.6.1 COMPANY OVERVIEW
  2. 9.6.2 COMPANY SNAPSHOT
  3. 9.6.3 OPERATING BUSINESS SEGMENTS
  4. 9.6.4 PRODUCT PORTFOLIO
  5. 9.6.5 BUSINESS PERFORMANCE
  6. 9.6.6 BUSINESS SEGMENTS
  7. 9.6.7 GEOGRAPHIC SEGMENTS
  8. 9.6.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.6.9 PRIMARY MARKET COMPETITORS
13. 9.7 BECTON, DICKINSON AND COMPANY.
14. 1. 9.7.1 COMPANY OVERVIEW
  2. 9.7.2 COMPANY SNAPSHOT
  3. 9.7.3 OPERATING BUSINESS SEGMENTS
  4. 9.7.4 PRODUCT PORTFOLIO
  5. 9.7.5 BUSINESS PERFORMANCE
  6. 9.7.6 BUSINESS SEGMENTS
  7. 9.7.7 GEOGRAPHIC SEGMENTS
  8. 9.7.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.7.9 PRIMARY MARKET COMPETITORS
15. 9.8 TORAY MEDICAL CO, LTD.
16. 1. 9.8.1 COMPANY OVERVIEW
  2. 9.8.2 COMPANY SNAPSHOT
  3. 9.8.3 OPERATING BUSINESS SEGMENTS
  4. 9.8.4 PRODUCT PORTFOLIO
  5. 9.8.5 BUSINESS PERFORMANCE
  6. 9.8.6 BUSINESS SEGMENTS
  7. 9.8.7 GEOGRAPHIC SEGMENTS
  8. 9.8.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.8.9 PRIMARY MARKET COMPETITORS
17. 9.9 TERUMO CORPORATION
18. 1. 9.9.1 COMPANY OVERVIEW
  2. 9.9.2 COMPANY SNAPSHOT
  3. 9.9.3 OPERATING BUSINESS SEGMENTS
  4. 9.9.4 PRODUCT PORTFOLIO
  5. 9.9.5 BUSINESS PERFORMANCE
  6. 9.9.6 BUSINESS SEGMENTS
  7. 9.9.7 GEOGRAPHIC SEGMENTS
  8. 9.9.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.9.9 PRIMARY MARKET COMPETITORS
19. 9.10 W. L. GORE AND ASSOCIATES, INC.
20. 1. 9.10.1 COMPANY OVERVIEW
  2. 9.10.2 COMPANY SNAPSHOT
  3. 9.10.3 OPERATING BUSINESS SEGMENTS
  4. 9.10.4 PRODUCT PORTFOLIO
  5. 9.10.5 BUSINESS PERFORMANCE
  6. 9.10.6 BUSINESS SEGMENTS
  7. 9.10.7 GEOGRAPHIC SEGMENTS
  8. 9.10.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.10.9 PRIMARY MARKET COMPETITORS
21. 9.11 TELEFLEX INCORPORATED
22. 1. 9.11.1 COMPANY OVERVIEW
  2. 9.11.2 COMPANY SNAPSHOT
  3. 9.11.3 OPERATING BUSINESS SEGMENTS
  4. 9.11.4 PRODUCT PORTFOLIO
  5. 9.11.5 BUSINESS PERFORMANCE
  6. 9.11.6 BUSINESS SEGMENTS
  7. 9.11.7 GEOGRAPHIC SEGMENTS
  8. 9.11.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.11.9 PRIMARY MARKET COMPETITORS
23. 9.12 QUANTA DIALYSIS TECHNOLOGIES LTD
24. 1. 9.12.1 COMPANY OVERVIEW
  2. 9.12.2 COMPANY SNAPSHOT
  3. 9.12.3 OPERATING BUSINESS SEGMENTS
  4. 9.12.4 PRODUCT PORTFOLIO
  5. 9.12.5 BUSINESS PERFORMANCE
  6. 9.12.6 BUSINESS SEGMENTS
  7. 9.12.7 GEOGRAPHIC SEGMENTS
  8. 9.12.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.12.9 PRIMARY MARKET COMPETITORS
25. 9.13 VANTIVE HEALTH LLC
26. 1. 9.13.1 COMPANY OVERVIEW
  2. 9.13.2 COMPANY SNAPSHOT
  3. 9.13.3 OPERATING BUSINESS SEGMENTS
  4. 9.13.4 PRODUCT PORTFOLIO
  5. 9.13.5 BUSINESS PERFORMANCE
  6. 9.13.6 BUSINESS SEGMENTS
  7. 9.13.7 GEOGRAPHIC SEGMENTS
  8. 9.13.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.13.9 PRIMARY MARKET COMPETITORS
27. 9.14 VYGON
28. 1. 9.14.1 COMPANY OVERVIEW
  2. 9.14.2 COMPANY SNAPSHOT
  3. 9.14.3 OPERATING BUSINESS SEGMENTS
  4. 9.14.4 PRODUCT PORTFOLIO
  5. 9.14.5 BUSINESS PERFORMANCE
  6. 9.14.6 BUSINESS SEGMENTS
  7. 9.14.7 GEOGRAPHIC SEGMENTS
  8. 9.14.8 KEY STRATEGIC MOVES AND DEVELOPMENT
  9. 9.14.9 PRIMARY MARKET COMPETITORS

TABLE 1. LATIN AMERICA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 2. HEMODIALYSIS MACHINES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 3. WATER TREATMENT SYSTEMS, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 4. ANCILLARY/OTHER HD EQUIPMENT, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 5. HD CONSUMABLES AND SUPPLIES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 6. HD AFTERMARKET SERVICES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 7. HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 8. PD CYCLERS / AUTOMATED PD MACHINES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 9. ANCILLARY PD EQUIPMENT, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 10. PD CONSUMABLES AND SUPPLIES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 11. PD AFTERMARKET SERVICES, MARKET VALUE, BY COUNTRY 2024-2030, (BILLION USD)
TABLE 12. PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 13. LATIN AMERICA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 14. HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 15. DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 16. HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 17. AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 18. LATIN AMERICA DIALYSIS MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
TABLE 19. ARGENTINA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 20. ARGENTINA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 21. BRAZIL DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 22. BRAZIL DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 23. CHILE DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 24. CHILE DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 25. COLUMBIA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 26. COLUMBIA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 27. REST OF LATAM DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
TABLE 28. REST OF LATAM DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
TABLE 29. FRESENIUS MEDICAL CARE AG AND CO. KGAA: COMPANY SNAPSHOT
TABLE 30. FRESENIUS MEDICAL CARE AG AND CO. KGAA: OPERATING BUSINESS SEGMENTS
TABLE 31. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRODUCT PORTFOLIO
TABLE 32. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 33. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 34. FRESENIUS MEDICAL CARE AG AND CO. KGAA: KEY STRATERGY
TABLE 35. DAVITA INC.: COMPANY SNAPSHOT
TABLE 36. DAVITA INC.: OPERATING BUSINESS SEGMENTS
TABLE 37. DAVITA INC.: PRODUCT PORTFOLIO
TABLE 38. DAVITA INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 39. DAVITA INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 40. DAVITA INC.: KEY STRATERGY
TABLE 41. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 42. BAXTER INTERNATIONAL INC.: OPERATING BUSINESS SEGMENTS
TABLE 43. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 44. BAXTER INTERNATIONAL INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 45. BAXTER INTERNATIONAL INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 46. BAXTER INTERNATIONAL INC.: KEY STRATERGY
TABLE 47. DIAVERUM DEUTSCHLAND GMBH: COMPANY SNAPSHOT
TABLE 48. DIAVERUM DEUTSCHLAND GMBH: OPERATING BUSINESS SEGMENTS
TABLE 49. DIAVERUM DEUTSCHLAND GMBH: PRODUCT PORTFOLIO
TABLE 50. DIAVERUM DEUTSCHLAND GMBH: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 51. DIAVERUM DEUTSCHLAND GMBH: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 52. DIAVERUM DEUTSCHLAND GMBH: KEY STRATERGY
TABLE 53. NIPRO CORPORATION: COMPANY SNAPSHOT
TABLE 54. NIPRO CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 55. NIPRO CORPORATION: PRODUCT PORTFOLIO
TABLE 56. NIPRO CORPORATION: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 57. NIPRO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 58. NIPRO CORPORATION: KEY STRATERGY
TABLE 59. B BRAUN: COMPANY SNAPSHOT
TABLE 60. B BRAUN: OPERATING BUSINESS SEGMENTS
TABLE 61. B BRAUN: PRODUCT PORTFOLIO
TABLE 62. B BRAUN: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 63. B BRAUN: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 64. B BRAUN: KEY STRATERGY
TABLE 65. BECTON, DICKINSON AND COMPANY.: COMPANY SNAPSHOT
TABLE 66. BECTON, DICKINSON AND COMPANY.: OPERATING BUSINESS SEGMENTS
TABLE 67. BECTON, DICKINSON AND COMPANY.: PRODUCT PORTFOLIO
TABLE 68. BECTON, DICKINSON AND COMPANY.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 69. BECTON, DICKINSON AND COMPANY.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 70. BECTON, DICKINSON AND COMPANY.: KEY STRATERGY
TABLE 71. TORAY MEDICAL CO, LTD.: COMPANY SNAPSHOT
TABLE 72. TORAY MEDICAL CO, LTD.: OPERATING BUSINESS SEGMENTS
TABLE 73. TORAY MEDICAL CO, LTD.: PRODUCT PORTFOLIO
TABLE 74. TORAY MEDICAL CO, LTD.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 75. TORAY MEDICAL CO, LTD.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 76. TORAY MEDICAL CO, LTD.: KEY STRATERGY
TABLE 77. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 78. TERUMO CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 79. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 80. TERUMO CORPORATION: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 81. TERUMO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 82. TERUMO CORPORATION: KEY STRATERGY
TABLE 83. W. L. GORE AND ASSOCIATES, INC.: COMPANY SNAPSHOT
TABLE 84. W. L. GORE AND ASSOCIATES, INC.: OPERATING BUSINESS SEGMENTS
TABLE 85. W. L. GORE AND ASSOCIATES, INC.: PRODUCT PORTFOLIO
TABLE 86. W. L. GORE AND ASSOCIATES, INC.: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 87. W. L. GORE AND ASSOCIATES, INC.: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 88. W. L. GORE AND ASSOCIATES, INC.: KEY STRATERGY
TABLE 89. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
TABLE 90. TELEFLEX INCORPORATED: OPERATING BUSINESS SEGMENTS
TABLE 91. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
TABLE 92. TELEFLEX INCORPORATED: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 93. TELEFLEX INCORPORATED: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 94. TELEFLEX INCORPORATED: KEY STRATERGY
TABLE 95. QUANTA DIALYSIS TECHNOLOGIES LTD: COMPANY SNAPSHOT
TABLE 96. QUANTA DIALYSIS TECHNOLOGIES LTD: OPERATING BUSINESS SEGMENTS
TABLE 97. QUANTA DIALYSIS TECHNOLOGIES LTD: PRODUCT PORTFOLIO
TABLE 98. QUANTA DIALYSIS TECHNOLOGIES LTD: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 99. QUANTA DIALYSIS TECHNOLOGIES LTD: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 100. QUANTA DIALYSIS TECHNOLOGIES LTD: KEY STRATERGY
TABLE 101. VANTIVE HEALTH LLC: COMPANY SNAPSHOT
TABLE 102. VANTIVE HEALTH LLC: OPERATING BUSINESS SEGMENTS
TABLE 103. VANTIVE HEALTH LLC: PRODUCT PORTFOLIO
TABLE 104. VANTIVE HEALTH LLC: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 105. VANTIVE HEALTH LLC: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 106. VANTIVE HEALTH LLC: KEY STRATERGY
TABLE 107. VYGON: COMPANY SNAPSHOT
TABLE 108. VYGON: OPERATING BUSINESS SEGMENTS
TABLE 109. VYGON: PRODUCT PORTFOLIO
TABLE 110. VYGON: SALES BY BUSINESS SEGMENTS (2022-2024)
TABLE 111. VYGON: SALES BY GEOGRAPHIC SEGMENTS (2022-2024)
TABLE 112. VYGON: KEY STRATERGY

FIGURE 1. BARGAINING POWER OF SUPPLIERS
FIGURE 2. BARGAINING POWER OF BUYERS
FIGURE 3. DEGREE OF COMPETITION
FIGURE 4. THREAT OF SUBSTITUTE
FIGURE 5. THREAT OF NEW ENTRANTS
FIGURE 6. LATIN AMERICA DIALYSIS MARKET VALUE, BY MODALITY, 2024-2030, (BILLION USD)
FIGURE 7. HEMODIALYSIS MACHINES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 8. WATER TREATMENT SYSTEMS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 9. ANCILLARY/OTHER HD EQUIPMENT, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 10. HD CONSUMABLES AND SUPPLIES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 11. HD AFTERMARKET SERVICES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 12. HEMODIALYSIS (HD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 13. PD CYCLERS / AUTOMATED PD MACHINES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 14. ANCILLARY PD EQUIPMENT, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 15. PD CONSUMABLES AND SUPPLIES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 16. PD AFTERMARKET SERVICES, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 17. PERITONEAL DIALYSIS (PD), MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 18. LATIN AMERICA DIALYSIS MARKET VALUE, BY END-USER, 2024-2030, (BILLION USD)
FIGURE 19. HOSPITALS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 20. DIALYSIS CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 21. HOMECARE, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 22. AMBULATORY SURGICAL CENTERS, MARKET VALUE, BY COUNTRY, 2024-2030, (BILLION USD)
FIGURE 23. LATIN AMERICA DIALYSIS MARKET VALUE, BY REGION 2024-2030, (BILLION USD)
FIGURE 24. ARGENTINA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 25. ARGENTINA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 26. BRAZIL DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 27. BRAZIL DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 28. CHILE DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 29. CHILE DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 30. COLUMBIA DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 31. COLUMBIA DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 32. REST OF LATAM DIALYSIS MARKET VALUE, BY MODALITY 2024-2030, (BILLION USD)
FIGURE 33. REST OF LATAM DIALYSIS MARKET VALUE, BY END-USER 2024-2030, (BILLION USD)
FIGURE 34. FRESENIUS MEDICAL CARE AG AND CO. KGAA: NET SALES, (2022-2024)
FIGURE 35. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRIMARY MARKET COMPETITORS
FIGURE 36. DAVITA INC.: NET SALES, (2022-2024)
FIGURE 37. DAVITA INC.: PRIMARY MARKET COMPETITORS
FIGURE 38. BAXTER INTERNATIONAL INC.: NET SALES, (2022-2024)
FIGURE 39. BAXTER INTERNATIONAL INC.: PRIMARY MARKET COMPETITORS
FIGURE 40. DIAVERUM DEUTSCHLAND GMBH: NET SALES, (2022-2024)
FIGURE 41. DIAVERUM DEUTSCHLAND GMBH: PRIMARY MARKET COMPETITORS
FIGURE 42. NIPRO CORPORATION: NET SALES, (2022-2024)
FIGURE 43. NIPRO CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 44. B BRAUN: NET SALES, (2022-2024)
FIGURE 45. B BRAUN: PRIMARY MARKET COMPETITORS
FIGURE 46. BECTON, DICKINSON AND COMPANY.: NET SALES, (2022-2024)
FIGURE 47. BECTON, DICKINSON AND COMPANY.: PRIMARY MARKET COMPETITORS
FIGURE 48. TORAY MEDICAL CO, LTD.: NET SALES, (2022-2024)
FIGURE 49. TORAY MEDICAL CO, LTD.: PRIMARY MARKET COMPETITORS
FIGURE 50. TERUMO CORPORATION: NET SALES, (2022-2024)
FIGURE 51. TERUMO CORPORATION: PRIMARY MARKET COMPETITORS
FIGURE 52. W. L. GORE AND ASSOCIATES, INC.: NET SALES, (2022-2024)
FIGURE 53. W. L. GORE AND ASSOCIATES, INC.: PRIMARY MARKET COMPETITORS
FIGURE 54. TELEFLEX INCORPORATED: NET SALES, (2022-2024)
FIGURE 55. TELEFLEX INCORPORATED: PRIMARY MARKET COMPETITORS
FIGURE 56. QUANTA DIALYSIS TECHNOLOGIES LTD: NET SALES, (2022-2024)
FIGURE 57. QUANTA DIALYSIS TECHNOLOGIES LTD: PRIMARY MARKET COMPETITORS
FIGURE 58. VANTIVE HEALTH LLC: NET SALES, (2022-2024)
FIGURE 59. VANTIVE HEALTH LLC: PRIMARY MARKET COMPETITORS
FIGURE 60. VYGON: NET SALES, (2022-2024)
FIGURE 61. VYGON: PRIMARY MARKET COMPETITORS

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

SWOT Analysis

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.

Download Free Sample

Full Name *

Please Enter Full Name

Business Email Id *

Please Enter Valid Email ID

Phone Number *

Please enter Country Code and Phone No

Message

Please enter message

Yes, I have read the Privacy Policy

Frequently Asked Questions

As per NMSC, the Latin America dialysis market was valued at USD 9.38 billion in 2025.

According to projections from Next Move Strategy Consulting, the Latin America dialysis market growth is anticipated to reach USD 13.96 billion by 2030.

Brazil and Mexico are leading the market due to high CKD prevalence, expanding healthcare infrastructure, and increased government support.

Introduction of portable dialysis devices, telehealth monitoring, and smart machines is helping enhance treatment efficiency, safety, and patient convenience.

High treatment costs, limited dialysis centers in rural regions, and uneven access to advanced or home-based dialysis systems remain major hurdles.

Purchase Options Flash
sale

Multi User

$3,917 $5595

Single User

$3,217 $4595

Enterprise

$5,317 $7595

Datapack

$1,817 $2595

Download Sample

Inquire Before Buying

Speak to Our Analyst

Share with Peers

Request Sample